Bone marrow derived cells in adult skeletal muscle tissue in humans
© Strömberg et al.; licensee BioMed Central Ltd. 2013
Received: 17 December 2012
Accepted: 10 April 2013
Published: 16 May 2013
During the past decade, several animal studies have demonstrated that in addition to local cells, cells from the bone marrow (BM) possess the ability to contribute to regeneration of injured skeletal muscle tissue. In addition, in mice, regular physical activity has been displayed to be a sufficient stimulus for BM-derived cell contribution to the muscle, indicating that this is part of the ongoing physiological remodeling of skeletal muscle. However, whether BM-derived cells participate in human skeletal muscle remodeling is not known. To this end, we analyzed the incorporation of BM-derived cells in healthy human skeletal muscle in women transplanted with male BM.
Skeletal muscle biopsies were obtained from the m. vastus lateralis of women transplanted with male donor hematopoietic stem cells 6 to 12 years earlier. Healthy women served as controls. Immunohistochemical staining for skeletal muscle fibers, satellite cells (SCs) or endothelial cells (ECs) combined with fluorescent in situ hybridization (FISH) of X and Y chromosomes was used to identify cells of BM origin within the biopsies. Three dimensional confocal imaging was performed to demonstrate colocalization of Y chromosome and DAPI within muscle fibers. To further investigate whether BM-derived cells incorporate into the SC niche, myoblasts were extracted from the biopsies from the transplanted women, cultured, and analyzed using XY FISH and immunocytochemistry.
Three dimensional confocal imaging indisputably demonstrated colocalization of Y chromosome and DAPI within muscle fibers. Some Y chromosomes were found within centrally located nuclei. No Y chromosomes were detected in CD56+ SCs in the tissue sections nor in the myoblasts cultured from the extracted SCs. Y chromosome+ ECs were found in all sections from the transplanted subjects. No Y chromosomes were found in the skeletal muscle biopsies obtained from healthy control women.
We demonstrate that BM-derived cells contribute to skeletal muscle fibers and ECs. Our results support that BM contribution to skeletal muscle occurs via direct fusion to muscle fibers, and that the contributing cells derive from the hematopoietic lineage. Thus, the present findings encourage further studies of the importance of this process for the physiological adaptation occurring throughout life.
KeywordsFluorescent in situ hybridization (FISH) Needle biopsies Satellite cell niche Vasculogenesis
In recent years, multipotent cells have attracted considerable interest because of their potential capacity to repair and remodel peripheral tissue. Skeletal muscle is an organ system that is under constant adaptation to changing work demands due to day-to-day physical activity and inactivity. This includes effects on the number of mitochondria, storage of substrates, enzyme activity levels, and changes in the contractility apparatus . In addition to changes in muscle fibers, extracellular structures and supporting cells surrounding the fibers adapt to altered work demands . The mature skeletal muscle cell is postmitotic; thus, muscle regeneration depends on the recruitment and fusion of progenitor cells with preexisting mature skeletal muscle fibers. The satellite cell (SC), which was identified in 1961 , is the residential stem cell of skeletal muscle tissue. However, the importance of this cell in the remodeling process was seriously recognized only recently [4, 5]. It has been proposed that the SC pool is supplemented with progenitor cells from other sources, such as the bone marrow (BM) [6–8]. An alternative route suggested for BM-derived cell contribution to skeletal muscle is via direct fusion to muscle fibers in response to a physiological stimulus such as injury [9, 10].
Another auxiliary structure with critical importance for skeletal muscle function is the capillary network surrounding each fiber, and alteration of the number of capillaries is a well-characterized extracellular remodeling process that occurs during skeletal muscle adaptation, both in humans and animals [1, 11–13]. The earlier predominant view was that any changes in the number of vessels in adults were related to the proliferation of existing vessels, i.e., angiogenesis or arteriogenesis. Currently, it has been shown that BM-derived endothelial progenitor cells (EPCs) contribute to vascular growth (vasculogenesis) in numerous animal models [14–16] and that the circulating level of these cells changes in human conditions of enhanced vascular formation [17–19]. Furthermore, several factors that stimulate vascular growth in skeletal muscle (e.g., vascular endothelial growth factor-A, the angiopoietins, and erythropoietin) have been shown to stimulate both the angiogenic and vasculogenic processes [20–23]. Nevertheless, there are no data on the contribution of BM-derived cells to physiological vascular remodeling of skeletal muscle tissue in humans; however, data demonstrating that BM-derived cells differentiate into endometrial endothelial cells (ECs) in a human female after BM transplantation  support such hypothesis.
The aim of the current study was to investigate whether cells from the BM incorporate into skeletal muscle tissue in adult humans. This was achieved by analyzing skeletal muscle biopsies from women transplanted with male BM. Our hypothesis was that BM-derived cells contribute to the SC pool, skeletal muscle fibers and ECs in skeletal muscle tissue in humans.
Study subjects and experimental model
Three non-smoking, moderately active female subjects transplanted with male haematopoietic stem cells 6 to 12 years previously participated in the study. Their age, height and weight ranged between 28 to 36 yrs, 161 to 178 cm, and 69 to 83 kg, respectively. All patients were on post-transplant hormonal replacement therapy and in remission. Patient A had suffered from myelodysplastic syndrome, and was transplanted with BM from an unrelated donor. She had two children, a son and a daughter aged 11 and 13, respectively, at the time of obtaining the biopsy. Patient B had acute myeloid leukaemia, and had received BM-derived peripheral blood stem cells from her brother. Patient C had chronic lymphatic leukaemia, and was transplanted with BM from her brother. Neither patient B nor C had biological children. Two healthy, non-smoking, moderately active women served as controls. Their age, height and weight ranged between 35 to 36 yrs, 164 to 170 cm, and 58 to 65 kg, respectively. One of the control subjects had two sons aged 4 and 7, respectively, at the time of obtaining the biopsy. The other control subject had two children, a son and a daughter, aged 3 and 5. Prior to the study, the experimental protocol was explained to all subjects and informed written consent for participation was obtained. The study was approved by the Ethics Committee at Karolinska Institutet and conformed to the Declaration of Helsinki.
Muscle biopsy samples were obtained using the percutaneous needle biopsy technique from the vastus lateralis muscle at rest. The biopsies were immediately divided in two pieces; one piece was frozen within 10 to 15 s in isopentane cooled to freezing by liquid nitrogen and stored at −80°C until analysis, and the other was stored overnight in PBS/1% penicillin streptomycin at 4°C. For the control subjects the whole biopsy was frozen and stored at −80°C until analysis.
Satellite cell isolation
About 30 mg of muscle tissue was put in a tube containing sterile PBS with 1% penicillin-streptomycin (Invitrogen AB, Stockholm, Sweden) and stored overnight at 4°C. After ~20 h, the biopsy was washed twice with PBS, cut in small pieces and digested in 5 mL 0.25% trypsin EDTA in 37°C, 5% CO2 with gentle agitation for 20 min. Undigested tissue was allowed to settle for 5 min and the supernatant was collected in DMEM-F12, with 20% FCS and 1% penicillin streptomycin. The cells were cultured until reaching ~70% confluence when a fraction of the cells was obtained for cytocentrifugation.
The cells were suspended at a concentration of 105 cells/mL and 100 μL were spun onto each glass slide (Superfrost/Plus microscope slides, Fisher Scientific, Pittsburgh, PA, USA). The slides were fixed in −20°C acetone for 10 min and then washed in PBS. Slides were blocked in PBS/4% BSA for 30 min in a humid chamber. A mouse anti-human desmin antibody (M0760, clone D33, Dako, Glostrup, Denmark) was added at a concentration of 1:200 in 1% BSA/PBS and the slides were incubated overnight in the cold room. The slides were washed in PBS before staining with the secondary rabbit-anti mouse Alexa488 antibody (A11059, Molecular Probes, Eugene, OR, USA) at 1:1000 in 1% BSA/PBS for 60 min in the humid chamber. After washing in PBS, the slides were mounted in Vectashield DAPI (406-diamidine-2-phenylidole-dihydrochloride)/antifade (Vector Laboratories Inc. Burlingame, CA, USA) and then analyzed for percentage of desmin positive cells.
The frozen muscle biopsies were cut into 4 μm sections and placed on Superfrost/Plus microscope slides (Fisher Scientific). For serial sections, one section was put on each glass slide in a series of slides. The sections were fixed for 10 min in −20°C acetone, and then dried before three 3 min washes in PBS. The slides were blocked in PBS/4% BSA for 30 min in a humid chamber, and were then incubated with the primary antibody overnight at 4°C in the humid chamber. The antibodies used were mouse anti-human CD31 at 1:500 (M0823, Dako), mouse anti-human CD56 (NCAM) at 1:50, (347740, Becton Dickinson, San Jose, CA, USA), sheep anti-human laminin at 1:10000 (PC128, The Binding Site, Birmingham, UK), mouse anti-human Caveolin-3 (A-3) at 1:500 (sc-5310, Santa Cruz Biotechnology Inc. Santa Cruz, CA, USA) and mouse anti-human CD68 at 1:500 (M0718, Dako). After washing the slides in PBS, they were incubated in the secondary rabbit-anti mouse Alexa488 antibody (A11059, Molecular Probes) at 1:500 and/or the donkey anti-goat TexasRed at 1:300 (ab6883, Abcam, Cambridge, UK) for 60 min in room temperature, washed again and mounted in VectaShield with or without DAPI (Vector Laboratories). The staining was evaluated before fluorescent in situ hybridization.
Fluorescent in situhybridization (FISH)
After antibody staining, the glass slides were put in 2× saline sodium-citrate (SSC) buffer, and the cover slips were allowed to fall off. The chromosome enumeration probes (CEP) for the X and Y chromosomes (Vysis CEP X (DXZ1) SpectrumGreen or SpectrumOrange Probe and CEP Y (DYZ1) SpectrumAqua or SpectrumGreen Probe), were mixed with hybridization buffer according to the manufacturer (Abbott-Vysis Inc Downers Grove, IL, USA); 1.5 μL of the probe solution were added to a round cover slip (Thermo Fischer Scientific, Menzel GmbH & Co KG, Braunschweig, Germany), and the glass slide was then put on top of the cover slip. The cover slip was sealed around the edges with rubber cement, to prevent the probe solution from drying out during hybridization. Glass slides and probe mixture were denatured together in a Vysis HYBrite (Abbot Diagnostics). The melt temperature was set to 73°C for 2 min and hybridization temperature 38°C for 20 hours. When the hybridization was complete, the rubber cement was removed from the cover slips, and the slides were immersed in 2×SSC until the cover slips fell off. The slides were then washed in 0.4×SSC/0.3% Igepal, 72°C for 2 min and then 2×SSC/0.1% Igepal at room temperature for 30 s, and subsequently allowed to air-dry in the dark before mounting in VectaShield antifade (Vector Laboratories) with DAPI or propidium iodide as nuclear staining.
Evaluation of immunohistochemistry and FISH staining
Evaluation and cell identification was done using an Olympus fluorescence microscope BH60 with appropriate filter set equipped with a CCD camera and connected to a Cyto-Vision image system (Applied Imaging Corp., San Jose, CA, USA) in which the results also were documented. Contribution of Y+ nuclei to skeletal muscle fibers was analyzed in sections stained with caveolin-3, while sections double-stained with laminin-1 and CD56 were analyzed for contribution to the SC pool. A cell stained with the marker CD56 containing a nucleus lying inside laminin-1 positive lamina was identified as an SC. Three sections from each subject, at least 80 μm apart, were completely examined by two independent investigators using an oil immersion objective with magnification 100×1.3. Some of the skeletal muscle fibers containing Y chromosomes were also evaluated using confocal microscopy. For evaluation of Y+ nuclei within ECs, two sections from each subject stained with CD31 were examined. To exclude for the possibility of the Y chromosome belonging to a leukocyte travelling within the vessel, serial sections stained with CD68 were performed and examined. After evaluating the sections for Y chromosomes, the sections were photographed using a Leica DMLA microscope equipped with a Leica DFC 420 C digital camera (Leica Microsystems AB, Sweden). The amount of myofibers and ECs per section was then calculated using the software Leica Qwin V. For myofibers, the tissue sections were photographed using the 5× objective. For ECs, the 20× objective was used and a picture was taken in a random location of the section. The area of the field was measured and the number of ECs was counted using Leica Qwin V. The area of the whole section was then measured at 5× magnification, and the number of ECs for the whole section was then estimated based on the assumption of equal distribution of ECs across the sections. The counting of ECs was performed in two different fields by two independent persons. For evaluation of Y chromosomes in the cytocentrifuged cells, the preparations were completely examined using an oil immersion objective with magnification 100×1.3. For each slide (n = 10 per subject), 4 visual fields were analyzed using the 40× objective for expression of desmin, a myogenic marker.
Tissue sections were visualized with a Zeiss LSM710 confocal system using a Plan-Apochromat 63×/1.40 Oil objective. Z-stacks were acquired sequentially using a 405 diode laser and the 488 laser line of the Argon laser to excite DAPI and SpectrumGreen, respectively. To determine whether a Y chromosome belonged to a muscle fiber nucleus, Y chromosome staining and DAPI nuclear staining had to colocalize and the nucleus of interest had to be on the same focal plane as the muscle membrane staining. Z-stacks are presented as maximum intensity projections. Three-dimensional rendering, maximum intensity projections and deconvolution were done with the AutoQuant X3 software.
Immunohistochemistry and XY-FISH
Number of Y chromosomes in skeletal muscle fibers and ECs
Detection of Y chromosomes in host skeletal muscle fiber and endothelial cell nuclei
No. of skeletal muscle fibers
No. of Y chromosomes in fibers
No. of ECs
No. of Y chromosomes in ECs
Subjects (n = 3)
In the current study, we demonstrated that Y chromosomes are present within myofibers and in cells with an endothelial phenotype/morphology in women transplanted with male hematopoietic stem cells. No Y chromosome positive SCs were detected in the tissue sections or in the cytocentrifuged cell population derived from SC isolation.
In tissue sections stained using XY FISH together with either caveolin-3, which stained the sarcolemma, or laminin-1, which stained the basal membrane, epifluorescence microscopy showed Y chromosomes present within myofibers. To further demonstrate colocalization of Y chromosome and DAPI nuclear staining within muscle fibers, three dimensional confocal imaging was performed. Interestingly, some of the Y chromosomes found within myofibers were observed in centrally located nuclei, which is indicative of a regenerating fiber . In the present study, no Y chromosomes were detected in the SC niche in tissue sections stained with laminin-1 together with CD56. Further, not a single Y chromosome was detected in desmin positive myoblasts in the cell cultures from the isolated SCs. In a study performed in mice, BM-derived cells were shown to be incorporated into the SC niche . The current data does not support such a mechanism; instead it suggests that BM-derived cells fuse directly with the muscle fibers rather than passing through a myogenic stem cell stage. This is also coherent with a very well performed study in mice, were an estimated number of 375,000 SCs were assayed to determine the mechanism behind haematopoietic stem cell contribution to skeletal muscle . In their experiments not a single SC was shown to derive from the BM, and BM contribution to skeletal muscle occurred through myeloid cell fusion to muscle fibers .
The observation of Y chromosomes in cells stained with CD31 support the notion that circulating cells incorporate into the skeletal muscle endothelium in humans. Importantly, to exclude the possibility of the Y chromosome belonging to a leukocyte travelling within the vessel only CD31+ Y chromosome+ cells without a CD68+ cell on the same localization in a serial section were counted. Since the discovery by Asahara et al. in 1997 of the formation of ECs from human BM mononuclear cells in mice, a large number of articles on EPCs have been published in various animal settings. This includes the contribution of EPCs to neovascularization of myocardium, brain and hindlimb in rodents after induced ischemia [16, 27, 28]. Still, even though the circulating level of EPCs is known to change in human conditions of enhanced vascular formation, to our knowledge only one earlier report exists of actual contribution to endothelium in humans, where BM-derived cells were shown to differentiate into endometrial ECs in a human female . Our study provides novel data regarding the contribution of BM-derived cells to skeletal muscle tissue in humans.
In the present study we have not been able to elaborate on the functionality of these incorporated cells. Because of the low number of BM-derived cells found in our study, one may think that this is a process with no physiological relevance. However, based on earlier findings in mice [8, 29], it is tempting to speculate on whether their number would have been higher if these women had been subjected to remodeling stimuli, such as habitual endurance-type exercise. Importantly, the number of skeletal muscle fibers containing Y chromosomes in our study is consistent with levels found in non-exercised mice [8, 26], in which the number of cells shown to increase in response to increased muscle activity from muscle overload, forced downhill running , and voluntary exercise . Moreover, the role of EPCs in vascular formation and repair is a largely unresolved question; do they act in a paracrine fashion to supply local cells with growth factors, or do they form ECs themselves? For instance, the beneficial effects of the injection of EPCs into patients with myocardial infarction are measured using markers of cardiac function, such as left ventricular ejection fraction, which does not reveal whether the injected cells have actually formed ECs [30, 31].
One could claim that the XY cells found in these women derive from male offspring. However, only one of the women had biological children and she gave birth to her son 11 years before the beginning of this study. In addition, not a single Y-chromosome containing cell was found in sections from the control women that had given birth to boys. Furthermore, as the women who participated in our study had received either BM transplantation or peripheral blood stem cells, the exact phenotype/origin of the BM-derived stem cells incorporated into muscle fibers remains undetermined. Regarding the BM-transplanted women, donor-derived cells may be mesenchymal stem cells derived from the BM stroma or hematopoietic stem cells. The woman transplanted with peripheral blood stem cells, however, exhibited the same level of donor-derived cells in her muscle tissue, indicating that the ability to form myonuclei or ECs lies in the hematopoietic lineage. Nevertheless, the contribution of mesenchymal stem cells to skeletal muscle tissue in the BM-transplanted women cannot be excluded in this study. Another issue is whether irradiation administered prior to BM transplantation affects the tissues and the systemic environment in a manner that causes the incorporation of BM-derived cells into tissues. However, irradiation was shown not to be a prerequisite for BM-derived cell contribution to myofiber regeneration in a study performed in mice .
In conclusion, the contribution of BM-derived cells to skeletal muscle fibers and ECs was demonstrated by obtaining skeletal muscle biopsies from women transplanted with male BM. The extent of contribution to muscle fibers was similar to the levels seen in transplanted mice not exposed to injury or exercise [8, 26]. Our results support that BM contribution to skeletal muscle occurs via direct fusion to muscle fibers, and that the contributing cells derive from the hematopoietic lineage. The present study encourages further studies of the importance of this process for the physiological adaptation occurring throughout life.
Written informed consent was obtained from the subjects for publication of this manuscript. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Bovine serum albumin
Endothelial progenitor cells
Fetal calf serum
Fluorescent in situ hybridization
Phosphate buffered saline
We thank associate professor Gunnar Schulte, Karolinska Institutet who performed the confocal imaging. His work is supported by grants from the Knut & Alice Wallenberg Foundation, the Swedish Medical Research Council and Karolinska Institutet.
This study was supported by grants from the Swedish Medical Research Council, the Wallenberg foundation, the Swedish National Centre for Research in Sports, the Swedish Medical Association and the Karolinska Institutet Foundation.
- Saltin B, Gollnick PD: Skeletal muscle adaptability: significance for metabolism and performance. Handbook of Physiology. Section 10, Skeletal Muscle. Edited by: Peachey LD. 1983, Bethesda: American Physiological Society, 555-631.
- Timmons JA, Jansson E, Fischer H, Gustafsson T, Greenhaff PL, Ridden J, Rachman J, Sundberg CJ: Modulation of extracellular matrix genes reflects the magnitude of physiological adaptation to aerobic exercise training in humans. BMC Biol. 2005, 3: 19-10.1186/1741-7007-3-19.PubMed CentralView ArticlePubMed
- Mauro A: Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 1961, 9: 493-495. 10.1083/jcb.9.2.493.PubMed CentralView ArticlePubMed
- Sherwood RI, Christensen JL, Conboy IM, Conboy MJ, Rando TA, Weissman IL, Wagers AJ: Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell. 2004, 119: 543-554. 10.1016/j.cell.2004.10.021.View ArticlePubMed
- Kadi F, Charifi N, Denis C, Lexell J, Andersen JL, Schjerling P, Olsen S, Kjaer M: The behaviour of satellite cells in response to exercise: what have we learned from human studies?. Pflugers Arch. 2005, 451: 319-327. 10.1007/s00424-005-1406-6.View ArticlePubMed
- Wagers AJ, Sherwood RI, Christensen JL, Weissman IL: Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002, 297: 2256-2259. 10.1126/science.1074807.View ArticlePubMed
- Torrente Y, Belicchi M, Sampaolesi M, Pisati F, Meregalli M, D’Antona G, Tonlorenzi R, Porretti L, Gavina M, Mamchaoui K, Pellegrino MA, Furling D, Mouly V, Butler-Browne GS, Bottinelli R, Cossu G, Bresolin N: Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest. 2004, 114: 182-195.PubMed CentralView ArticlePubMed
- LaBarge MA, Blau HM: Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell. 2002, 111: 589-601. 10.1016/S0092-8674(02)01078-4.View ArticlePubMed
- Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998, 279: 1528-1530. 10.1126/science.279.5356.1528.View ArticlePubMed
- Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC: Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999, 401: 390-394.PubMed
- Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992, 72: 369-417.PubMed
- Gustafsson T, Kraus WE: Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci. 2001, 6: D75-D89. 10.2741/gustafss.View ArticlePubMed
- Gustafsson T: Vascular remodelling in human skeletal muscle. Biochem Soc Trans. 2011, 39: 1628-1632. 10.1042/BST20110720.View ArticlePubMed
- Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997, 275: 964-967. 10.1126/science.275.5302.964.View ArticlePubMed
- Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 2000, 97: 3422-3427. 10.1073/pnas.97.7.3422.PubMed CentralView ArticlePubMed
- Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001, 103: 634-637. 10.1161/01.CIR.103.5.634.View ArticlePubMed
- Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S: Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res. 2001, 88: 167-174. 10.1161/01.RES.88.2.167.View ArticlePubMed
- Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T: Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001, 103: 2776-2779. 10.1161/hc2301.092122.View ArticlePubMed
- Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001, 89: E1-E7. 10.1161/hh1301.093953.View ArticlePubMed
- Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S: Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci. 2001, 938: 36-45. Discussion 45–37View ArticlePubMed
- Hiratsuka S: Vasculogenensis, angiogenesis and special features of tumor blood vessels. Front Biosci. 2011, 16: 1413-1427. 10.2741/3796.View Article
- Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003, 102: 1340-1346. 10.1182/blood-2003-01-0223.View ArticlePubMed
- Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S: Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001, 193: 1005-1014. 10.1084/jem.193.9.1005.PubMed CentralView ArticlePubMed
- Mints M, Jansson M, Sadeghi B, Westgren M, Uzunel M, Hassan M, Palmblad J: Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Hum Reprod. 2008, 23: 139-143.View ArticlePubMed
- Charge SB, Rudnicki MA: Cellular and molecular regulation of muscle regeneration. Physiol Rev. 2004, 84: 209-238. 10.1152/physrev.00019.2003.View ArticlePubMed
- Camargo FD, Green R, Capetanaki Y, Jackson KA, Goodell MA: Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med. 2003, 9: 1520-1527. 10.1038/nm963.View ArticlePubMed
- Zhang ZG, Zhang L, Jiang Q, Chopp M: Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res. 2002, 90: 284-288. 10.1161/hh0302.104460.View ArticlePubMed
- Yamahara K, Sone M, Itoh H, Yamashita JK, Yurugi-Kobayashi T, Homma K, Chao TH, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Fukunaga Y, Tamura N, Nakao K: Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One. 2008, 3: e1666-10.1371/journal.pone.0001666.PubMed CentralView ArticlePubMed
- Palermo AT, Labarge MA, Doyonnas R, Pomerantz J, Blau HM: Bone marrow contribution to skeletal muscle: a physiological response to stress. Dev Biol. 2005, 279: 336-344. 10.1016/j.ydbio.2004.12.024.View ArticlePubMed
- Yousef M, Schannwell CM, Kostering M, Zeus T, Brehm M, Strauer BE: The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol. 2009, 53: 2262-2269. 10.1016/j.jacc.2009.02.051.View ArticlePubMed
- Leistner DM, Fischer-Rasokat U, Honold J, Seeger FH, Schachinger V, Lehmann R, Martin H, Burck I, Urbich C, Dimmeler S, Zeiher AM, Assmus B: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol. 2011, 100: 925-934. 10.1007/s00392-011-0327-y.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.